menu Search
Hepa-Merz

Hepa-Merz Adverse Reactions

l-ornithine-l-aspartate

Manufacturer:

Merz Pharmaceuticals

Distributor:

Zuellig
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Adverse Reactions
Granules: See Table 1.

Click on icon to see table/diagram/image

Gastrointestinal disorders: Uncommon: Nausea, vomiting, stomachache, flatulence, diarrhea.
Musculoskeletal and connective tissue disorders: Very rare: pain in the limbs.
These undesirable effects are usually transient and do not require withdrawal of the medicine.
Orange yellow S (E 110) can trigger allergic reactions.
Infusion: Based on clinical and post-marketing experience the information on the frequency of adverse reactions is stated as follows. The frequency categories are defined as follows. (See Table 2.)

Click on icon to see table/diagram/image

Immune system disorders: Not known: Hypersensitivity, anaphylactic reaction.
Gastrointestinal disorders: Uncommon: Nausea. Rare: Vomiting.
Generally, however, these gastrointestinal symptoms are transient, and do not necessitate discontinuation of treatment with this medicinal product. They disappear on reduction of the dose or infusion rate.
View ADR Reporting Link